Company Filing History:
Years Active: 1990-1992
Title: Goran Kronvall: Innovator in Protein Research
Introduction
Goran Kronvall is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of protein research, particularly through his innovative patents. With a total of 2 patents, Kronvall's work has had a substantial impact on biotechnology.
Latest Patents
Kronvall's latest patents include a hybrid DNA molecule capable of cellular expression, which comprises the DNA sequence for protein G. This invention highlights the molecule's ability to maintain substantially the same IgC binding properties as naturally occurring protein G. Additionally, the DNA sequence can code for both fragments of protein G and the full protein itself, which can be isolated from streptococcal DNA. Another significant patent involves a process for recovering a cell wall protein, particularly a Fc-receptor, from streptococcal bacteria. This process utilizes proteolytic enzymes to solubilize the cell wall protein, allowing for the recovery of Fc-receptor type III (protein G) with selective IgG-binding capability.
Career Highlights
Throughout his career, Goran Kronvall has worked with prominent companies such as Pharmacia AB and Pharmacia LKB Biotechnology AB. His experience in these organizations has contributed to his expertise in protein research and biotechnology.
Collaborations
Kronvall has collaborated with notable individuals in his field, including Lars Bjorck and Gunnar Lindahl. These partnerships have further enhanced his research and innovation in protein-related technologies.
Conclusion
Goran Kronvall's contributions to protein research through his patents and collaborations have established him as a significant figure in biotechnology. His innovative work continues to influence the field and pave the way for future advancements.